Heart Test Laboratories Inc. Common Stock (HSCS) | Stock Price, Analysis, News, Fundaments & Technical Information

stock

Heart Test Laboratories Inc. Common Stock

NASDAQ | HSCS

2.84

USD

+0.04 (+1.43%)

AT CLOSE (AS OF Apr 3, 2025)

$3M

MARKET CAP

P/E Ratio

-7.61

EPS

$14

52 Week High

$2.4

52 Week Low

LIFE SCIENCES

Sector

HSCS Chart

Area

Trade Smarter

Take control of your trading journey with a set of smart tools for serious trades

Backtests

Strategy Backtester designed to automate your backtesting and revolutionize the way you trade

Learn More About Backtests

Scanner

Leverage the power of AI to detect valuable opportunities and gain the most out of the markets.

Learn More About Scanner

Signals

Automate your trading workflow with AI-powered trading signals to execute trades automatically.

Learn More About Signals

Journal

Record your trades and performance to improve your trading with AfterPullback’s Trading Journal

Learn More About Journal

HSCS Technicals

Tags:

HSCS Earnings

Yearly Income Statement (As of Apr 30, 2024)

Field	Value (USD)
Gross Profit	$13K
Total Revenue	$19K
Cost Of Revenue	$6.1K
Costof Goods And Services Sold	$6.1K
Operating Income	-$6.3M
Selling General And Administrative	$3.4M
Research And Development	$2.9M
Operating Expenses	$6.3M
Investment Income Net	-
Net Interest Income	-$354K
Interest Income	-
Interest Expense	$354K
Non Interest Income	$19K
Other Non Operating Income	$55K
Depreciation	$28K
Depreciation And Amortization	$95K
Income Before Tax	-$6.6M
Income Tax Expense	-$95K
Interest And Debt Expense	-
Net Income From Continuing Operations	-$6.6M
Comprehensive Income Net Of Tax	-$6.6M
Ebit	-$6.3M
Ebitda	-$6.2M
Net Income	-$6.6M

Revenue & Profitability

Earnings Performance

HSCS Financials

Highlights

Balance Sheet

Cash Flow

Income Statement

Yearly

Quarterly

yearly Balance Sheet (As of Apr 30, 2024)

Field	Value (USD)
Total Assets	$9.5M
Total Current Assets	$7.4M
Cash And Cash Equivalents At Carrying Value	$5.8M
Cash And Short Term Investments	$5.8M
Inventory	$629K
Current Net Receivables	-
Total Non Current Assets	$2.1M
Property Plant Equipment	$98K
Accumulated Depreciation Amortization Ppe	$500K
Intangible Assets	$1.6M
Intangible Assets Excluding Goodwill	$1.6M
Goodwill	-$1.6B
Investments	-
Long Term Investments	-
Short Term Investments	-
Other Current Assets	$40K
Other Non Current Assets	-
Total Liabilities	$2.2M
Total Current Liabilities	$1.8M
Current Accounts Payable	$448K
Deferred Revenue	$0
Current Debt	$500K
Short Term Debt	$602K
Total Non Current Liabilities	$434K
Capital Lease Obligations	$536K
Long Term Debt	$500K
Current Long Term Debt	$500K
Long Term Debt Noncurrent	-
Short Long Term Debt Total	$500K
Other Current Liabilities	$34K
Other Non Current Liabilities	-
Total Shareholder Equity	$7.3M
Treasury Stock	-
Retained Earnings	-$67M
Common Stock	$677
Common Stock Shares Outstanding	$677K

yearly Cash Flow (As of Apr 30, 2024)

Field	Value (USD)
Operating Cashflow	-$6.1M
Payments For Operating Activities	$13K
Proceeds From Operating Activities	-
Change In Operating Liabilities	-$271K
Change In Operating Assets	$233K
Depreciation Depletion And Amortization	$131K
Capital Expenditures	$125K
Change In Receivables	-
Change In Inventory	-$47K
Profit Loss	-$6.6M
Cashflow From Investment	-$125K
Cashflow From Financing	$10M
Proceeds From Repayments Of Short Term Debt	-
Payments For Repurchase Of Common Stock	-
Payments For Repurchase Of Equity	-
Payments For Repurchase Of Preferred Stock	-
Dividend Payout	-
Dividend Payout Common Stock	-
Dividend Payout Preferred Stock	-
Proceeds From Issuance Of Common Stock	-
Proceeds From Issuance Of Long Term Debt And Capital Securities Net	-
Proceeds From Issuance Of Preferred Stock	-
Proceeds From Repurchase Of Equity	$334K
Proceeds From Sale Of Treasury Stock	-
Change In Cash And Cash Equivalents	-
Change In Exchange Rate	-
Net Income	-$6.6M

yearly Income Statement (As of Apr 30, 2024)

Field	Value (USD)
Gross Profit	$13K
Total Revenue	$19K
Cost Of Revenue	$6.1K
Costof Goods And Services Sold	$6.1K
Operating Income	-$6.3M
Selling General And Administrative	$3.4M
Research And Development	$2.9M
Operating Expenses	$6.3M
Investment Income Net	-
Net Interest Income	-$354K
Interest Income	-
Interest Expense	$354K
Non Interest Income	$19K
Other Non Operating Income	$55K
Depreciation	$28K
Depreciation And Amortization	$95K
Income Before Tax	-$6.6M
Income Tax Expense	-$95K
Interest And Debt Expense	-
Net Income From Continuing Operations	-$6.6M
Comprehensive Income Net Of Tax	-$6.6M
Ebit	-$6.3M
Ebitda	-$6.2M
Net Income	-$6.6M

HSCS Profile

Heart Test Laboratories Inc. Common Stock Profile

Sector: LIFE SCIENCES

Industry: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES

Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company is headquartered in Southlake, Texas.

Symbol	Price	Change %	Market Cap	Volume
DMN	$0.02	13.04%	-	706,860,781
NVDA	$103.14	-6.59%	$2.68T	263,349,217
LCID	$2.34	-2.30%	$7.67B	187,389,814
F	$9.68	-4.68%	$39.53B	173,285,336
PTIX	$0.43	91.50%	$4.04M	173,208,693

Symbol	Price	Change %	Market Cap	Volume
JNJ	$155.36	1.38%	$399.65B	10,356,920
PG	$172.76	1.92%	$399.61B	6,083,153
NVO	$67.60	-0.95%	$308.32B	7,033,051
AZN	$74.32	2.91%	$225.70B	5,306,182
MRK	$86.76	0.18%	$220.07B	7,844,359

Symbol	Price	Change %	Market Cap	Volume
VCIG	$6.06	1,818.33%	$26.40M	302,396
MKTW	$9.20	1,686.75%	$19.91M	106,995
ICCT	$4.38	111.59%	$9.78M	168,784,937
PTIX	$0.43	91.50%	$4.04M	173,208,693
MRM	$0.65	74.84%	$2.91M	51,693,935

Symbol	Price	Change %	Market Cap	Volume
ALDX	$1.42	-73.33%	$326.91M	20,249,631
RFAC	$2.70	-68.60%	$8.44M	605,339
PKBO	$0.02	-67.86%	$531.87K	66,140
TCBP	$0.50	-67.53%	$360.37K	1,955,586
OMQS	$0.04	-66.36%	$1.50M	950,669

Quick Links

HSCS $2.84 (+1.43%) Quote details